Accelerate Diagnostics Stock News

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen

A alian

Healthcare Publisher, Kalorama Information, shares recent trends observed from its ongoing study monitoring the impact of COVID-19 on clinical labs.

THOR's tipi and garden will be running in a socially distant manner

Merck Underscores Commitment to HIV with New Data Analyses to be Presented at AIDS 2020: Virtual

Insider buying doubled last week. Notable Insider Buys: AXIS Capital Holdings Limited, HC2 Holdings, Inc., Accelerate Diagnostics, Inc., Liquidity Services, Inc

The COVID-19 pandemic and its impact on the world has made a growing number of people realize how many of our everyday activities depend on software. We

KEYTRUDA® Approved in China for Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Prosegue la mobilitazione dei sindacati sulla situazione dell'Ast di Terni dopo l'annuncio da parte di ThyssenKrupp della ricerca di nuovi partner o di una possibile cessione. (ANSA)

Accelerate Diagnostics Inc (NASDAQ:AXDX) was the target of unusually large options trading activity on Thursday. Traders purchased 1,713 put options on the stock. This represents an increase of 1,416%